Ovid Therapeutics Inc OVID
NAS: OVID | ISIN: US6904691010 14/11/2024
1,150 USD (-5,74%)
(-5,74%)
14/11/2024
Profiel Ovid Therapeutics Inc
Website: www.ovidrx.com
Hoofdzetel: New York, New York Verenigde Staten
CEO: Jeremy Levin
Werknemers: 55